Loss of FUT8 in renal tubules ameliorates ischemia‐reperfusion injury‐induced renal interstitial inflammation transition to fibrosis via the TLR3NF‐κB pathway

Author:

Li Zhitong1ORCID,Hao Jiaojiao1,Li Longkai1,Shen Nan1,Wang Dapeng1,Wang Nan1,Wen Xinyu1,Wang Weidong1,Qin Biaojie1,Tang Qingzhu1,Guo Xianan1,Song Huiyi2,Du Xiangning1,Yang Fan1,Lin Hongli1

Affiliation:

1. Department of Nephrology The First Affiliated Hospital of Dalian Medical University Dalian China

2. Clinical Laboratory of Integrative Medicine The First Affiliated Hospital of Dalian Medical University Dalian China

Abstract

AbstractRenal ischemia‐reperfusion injury (IRI) is a common reason of acute kidney injury (AKI). AKI can progress to chronic kidney disease (CKD) in some survivors. Inflammation is considered the first‐line response to early‐stage IRI. We previously reported that core fucosylation (CF), specifically catalyzed by α‐1,6 fucosyltransferase (FUT8), exacerbates renal fibrosis. However, the FUT8 characteristics, role, and mechanism in inflammation and fibrosis transition remain unclear. Considering renal tubular cells are the trigger cells that initiate the fibrosis in the AKI‐to‐CKD transition in IRI, we targeted CF by generating a renal tubular epithelial cell (TEC)‐specific FUT8 knockout mouse and measured FUT8‐driven and downstream signaling pathway expression and AKI‐to‐CKD transition. During the IRI extension phase, specific FUT8 deletion in the TECs ameliorated the IRI‐induced renal interstitial inflammation and fibrosis mainly via the TLR3 CF–NF‐κB signaling pathway. The results firstly indicated the role of FUT8 in the transition of inflammation and fibrosis. Therefore, the loss of FUT8 in TECs may be a novel potential strategy for treating AKI–CKD transition.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3